Trials / Completed
CompletedNCT01656538
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
A Randomized Phase II Study of Reolysin For Patients Receiving Standard Weekly Paclitaxel Therapy as Therapy For Advanced/Metastatic Breast Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Canadian Cancer Trials Group · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Researchers doing this study want to evaluate the side effects of Reolysin when given together with paclitaxel. As these drugs have not been given together before, 6-9 patients will be treated with paclitaxel plus reolysin to ensure that side effects are tolerable.
Detailed description
The purpose of the randomized part of this study is to find out if giving Reolysin in combination with paclitaxel can offer better results than standard therapy with paclitaxel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paclitaxel | |
| DRUG | Reolysin |
Timeline
- Start date
- 2013-02-20
- Primary completion
- 2016-11-18
- Completion
- 2018-02-14
- First posted
- 2012-08-03
- Last updated
- 2023-08-04
Locations
7 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01656538. Inclusion in this directory is not an endorsement.